Jobs at the Center for Biologics Evaluation and Research (CBER)
CBER has unique opportunities for individuals with backgrounds in science or administration to fill positions involved in the regulation and research of blood, vaccines and therapeutics. Employment opportunities offer competitive salaries and excellent benefits. We invite you to apply for one of the positions listed below if you are seeking a challenging career opportunity.
Browse all FDA positions on USAJobs
For general information on qualifications for Medical Officers, scientists (Biologist, Chemist, Microbiologist, etc.), Consumer Safety Officers and other positions, please visit FDA’s Career Descriptions page.
CBER positions (other than those listed on USAJobs)
- CBER Cures Vacancy Announcement - Branch Chief, AD-0602-Band D, Office of Therapeutic Products (OTP), Office of Clinical Evaluation (OCE)
Closes: June 16, 2023 - CBER Cures Vacancy Announcement - Lead Physician (Hematology), AD-0602-Band D, Office of Therapeutic Products (OTP), Office of Clinical Evaluation (OCE)
Closes: July 3, 2023 - CBER Cures Vacancy Announcement - Physician (Hematology), AD-0602-Band C, Office of Therapeutic Products (OTP), Office of Clinical Evaluation (OCE)
Closes: July 3, 2023 - CBER Cures Vacancy Announcement – Clinical Pharmacologist Reviewer, AD-Band D, Office of Therapeutic Products (OTP), Office of Clinical Evaluation (OCE), Division of Clinical Evaluation Hematology (DCEH), Benign Hematology Branch (BHB)
Closes: July 3, 2023 - Staff Fellow/Visiting Associate – Molecular Virologist
Closes: July 7, 2023 - CBER Cures Vacancy Announcement – Physician, AD-0602-Band C, Office of Therapeutic Products (OTP)
Open continuously
CBER's Fellowship Programs
- CBER Service Fellowship Program
Provides a mechanism for the temporary employment, training, and professional development of promising postdoctoral scientists for a period of limited duration. - Regenerative Medicine Fellowship
Fellowship under the CBER Service Fellowship Program in the Office of Tissues and Advanced Therapies (OTAT) aims to enhance FDA's ability to regulate regenerative medicine products and support the development of highly trained scientists and engineers with unique multi-center experience. - National Cancer Institute (NCI) and FDA Interagency Oncology Task Force Joint Fellowship (IOTF)
Offers fellowship training to a cadre of scientists in research and research-related regulatory review, policies, and regulations to develop a skill set bridging two distinct processes. - CBER Fellows Association
Serves as a community to respresent the interests of CBER ORISE, Service, and Commissioner's Fellows. Members of CFA will provide fellow representation on relevant CBER committees agreed to by CFA and CBER leadership. - Oak Ridge Institute for Science and Education (ORISE) Research Participation Training Program for CBER
Provides temporary scientific training for domestic and foreign scientists having a background or interest in medical, biological, chemical, toxicological, mathematical/statistical, or other related sciences.